Openbaarmaking van transparantiekennisgevingen van BlackRock, Inc. Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 16 april 2026 – 18:00 CET Openbaarmaking van transparantiekennisgevingen van BlackRock, Inc. Overeenkomstig de Belgische Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in beursgenoteerde vennootschappen, ontving Fagron twee transparantiekennisgevingen van BlackRock, Inc., gedateerd op 9 en 10 april 2026. Kennisgevingen van BlackRock, Inc. Op 14 april 2026 ontving Fagron twee transparantiekennisgevingen van BlackRock, Inc. Na deze t...
Disclosure of transparency notifications from BlackRock, Inc. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 April 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received two transparency notifications from BlackRock, Inc., dated 9 and 10 April 2026. Notifications from BlackRock, Inc. On 14 April 2026, Fagron received two transparency notifications from BlackRock, Inc. Following these transactions, BlackRock's effective ...
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its shareholders and holders of subscription rights to attend its Ordinary General Meeting and Extraordinary General Meeting, to be held on Monday, 11 May 2026, starting at 15:00 CEST. The Extraordinary General Meeting will be held before notary and will take place immediately following the Ordinary General Meeting. Both meetings ...
Fagron organiseert Gewone en Buitengewone Algemene Vergadering op 11 mei 2026 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 10 april 2026 – 7:00u CEST Fagron organiseert Gewone en Buitengewone Algemene Vergadering op 11 mei 2026 Fagron NV nodigt haar aandeelhouders en houders van inschrijvingsrechten uit om deel te nemen aan de Gewone Algemene Vergadering en Buitengewone Algemene Vergadering, die plaatsvinden op maandag 11 mei 2026, met aanvang om 15:00 uur (CEST). Aansluitend op de Gewone Algemene Vergadering zal de Buitengewone Algemene Vergadering voor notaris wo...
Euronext: Unsurprisingly strong quarter. Fagron: Somewhat softer 1Q26 expected, FY guidance maintained. Randstad: Preview 1Q26F results due 22 April; consensus released. Staffing: French staffing: February touch softer but March outlook better. Theon International: Teaming up with Rheinmetall
Fagron reported 1Q26 revenues 1% above CSS expectations. Organic revenue growth of 3.2% at CER was supported by all regions, driven in particular by DD growth in Latin America. Despite losing the GLP-1 tailwind, North America still delivered positive organic growth. The continued focus on Brands is clearly paying off, with 22.6% organic revenue growth at CER y/y. Acquisition integrations are progressing as planned. FY26 guidance for MDS to HSD organic revenue growth at CER is reiterated, Fagron ...
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 April 2026 – 7:00 AM CET Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth Fagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 31 March 2026. Key Highlights Revenue of €263.4 million, up 10.3% on a reported basis (15.0% at CER1), supported by incremental M&A contribution and outstanding performance in Latin AmericaOr...
Fagron rapporteert in het eerste kwartaal een solide omzet van € 263 miljoen, met een omzetgroei van 10% Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 9 april 2026 – 7:00 uur CET Fagron rapporteert in het eerste kwartaal een solide omzet van € 263 miljoen, met een omzetgroei van 10% Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, publiceert vandaag haar kwartaalresultaten voor de periode eindigend op 31 maart 2026. Belangrijkste hoogtepunten Omzet van € 263,4 miljoen, een stijging van 10,3% op basis van gerapporteerde cijfers (15,0% tege...
We update our estimates with our c.6% higher Adj. EBITDA estimates for 2026F-28F largely driven by recent M&A's. We expect Fagron's trading update on 9 April to point to a somewhat softer quarter, reflecting temporary headwinds in the North American compounding segment. However, Fagron should reiterate its FY26 guidance of mid- to high-single digit organic revenue growth as growth should spring back in 2H26 as GLP1 headwinds fade. We reiterate our BUY recommendation and €27 per share target pric...
The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continues unabated. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. KBC macro-econimists have hiked the inflation expectation for 2026 from 1.9% to 3.3%. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We continue our defensive stance in our Benelux Dyna...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.